An investigation for investors in Davita Inc (NYSE:DVA) shares over potential securities laws violations by Davita Inc was announced and NYSE:DVA stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 01/17/2017 -- An investigation was announced for investors in Davita Inc (NYSE:DVA) shares over potential securities laws violations by Davita Inc in connection certain financial statements.
Investors who purchased shares of Davita Inc (NYSE:DVA), have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Davita Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
On January 6, 2017, after the close of trading, an article was published revealing that Davita Inc allegedly had received subpoenas from federal prosecutors seeking "the production of information related to charitable premium assistance" in connection with Davita Inc's ties to the American Kidney Fund, a charity that helps patients pay for kidney dialysis.
Shares of Davita Inc (NYSE:DVA) declined to $62.88 per share on January 9, 2017.
On January 13, 2017, NYSE:DVA shares closed at $63.93 per share.
Those who purchased shares of Davita Inc have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego